Shopping Cart
- Remove All
- Your shopping cart is currently empty
ORIC-944 is an orally available and selective variant of PRC2 with anticancer activity for prostate cancer research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | In Stock | |
50 mg | Inquiry | In Stock |
Description | ORIC-944 is an orally available and selective variant of PRC2 with anticancer activity for prostate cancer research. |
In vivo | Single agent tumor growth inhibition was observed for ORIC-944 in prostate cancer xenograft models. ORIC-944 also improved ARPI antitumor activity in preclinical combination studies and demonstrated in vitro synergy. [2] |
Alias | ORIC944 |
Molecular Weight | 456.52 |
Formula | C26H25FN6O |
Cas No. | 2369769-29-7 |
Smiles | N#CC=1N=C2C(=CN=C(NCC=3C(F)=CC=C4OCCC43)N2C1)C5=CC=C(C=C5C)CN(C)C |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80.00 mg/mL (175.24 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.